DRUG STUDY

Patient’s Name:________________________________________ Age/Gender:_______________

Diagnosis:_____________________________________________

Name of Drug Date Classificatio Mechanism Specific Contraindicat Adverse Nursing

(Brand &Generic) Ordered/ n of Action Indication ion Effect/ Side Responsibilities
Dosage/ Effect
Route/
Frequency/
Timing

Ciprofloxacin 8/14/10 Antibacterial Bactericidal; For With allergy CNS: Continue therapy for
500mg 1 tab interferes treatment of to Headache 2 days after signs &
PO/NGT with DNA nasocomial ciprofloxacin, Dizziness symptoms of
BID (8AM- replication pneumonia norfloxacin, infection are gone.
6PM) in by h. pregnancy GI:
susceptible influenzae and Nausea Give oral drug 1
gram- lactation. Vomiting hour before or 2
negative diarhea hours after meals
bacteria Use with glass of water
preventing continuously
cell with renal Encourage patient to
reproduction dysfunction, complete full course
seizures, of therapy
tendinitis or
tendon
ruptured
associated
with
florquinolone
use.
 DRUG STUDY
Patient’s Name:________________________________________ Age/Gender:_______________
Diagnosis:_____________________________________________

Name of Drug Date Classificatio Mechanism Specific Contraindicat Adverse Effect/ Nursing
(Brand &Generic) Ordered/ n of Action Indicatio ion Side Effect Responsibilities’
Dosage/ n
Route/
Frequenc
y/ Timing
(parasympathomi
Pyridostigmine 8/14/10 Cholinestera Increases Treatme Hypersensiti metic effects) Overdose of
(mestinon) 60 mg ½ se inhibitor concentrati nt of vity anticholinesterase
tab on of myasthe CV: drug can cause
PO NGT Antimyasthe acetylcholin nia Adverse Bradycardia muscle weakness
TID(8-1- nic agent e at sites of gravis. reaction to Cardiac (cholinergic crisis)
6) cholinergic bromides Arrhythmias that is difficult to
transmissio differentiate from
n and Intestinal or EENT: myasthenic
prolongs urogenital Lacrimation weakness.
the effects obstruction Miosis
of peritonitis
acetylcholin and lactation GI:
e by Salivation
reversibly Use Dyspagia
in cautiously Nausea
habiting with asthma, Vomiting
/blocking peptic ulcer,
acetyl bradycardia, GU:
cholinestera cardiac Urinary frequency
se, thus arrhythmias, And incontinence
facilitating recent
transmissio coronary
n at occlusion.
neuromusc
 ular
junction.

DRUG STUDY
Patient’s Name:________________________________________ Age/Gender:_______________
Diagnosis:_____________________________________________

Name of Drug Date Classificatio Mechanism Specific Contraindicati Adverse Nursing

(Brand &Generic) Ordered/ n of Action Indication on Effect/ Side Responsibilities
Dosage/ Effect
Route/
Frequency/
Timing
Ferrous sulfate 8/14/10 Iron Elevates Prevention Hypersensitivi CNS: Confirm that
1 cap preparation serum iron and ty Toxicity CNS patient does have
PO/NGT concentratio treatment Acidosis iron deficiency
OD (8am) Iron n which then of iron Severe anemia before
supplement converted to deficiency hypotension GI: treatment.
hemoglobin anemias. GI upset
or trapped Peptic ulcer, Anorexia Give drug with
in the Dietary regional Nausea meals(avoid
reticulo supplement enteritis, Vomiting milk,eggs, coffee
endothelial for iron. hemolytic Constipation and tea) if GI
cell for anemia’s Diarrhea discomfort is
storages Dark stool severe, and slowly
and Temporary increase to build up
eventual staining of tolerance
conversion teeth.
to a usable Inform patient that
form of iron. do not taking
antacids or
tetracylines

DRUG STUDY
Patient’s Name:________________________________________ Age/Gender:_______________
Diagnosis:_____________________________________________

Name of Drug Date Classificatio Mechanism Specific Contraindicati Adverse Nursing

(Brand &Generic) Ordered/ n of Action Indication on Effect/ Side Responsibilities
Dosage/ Effect
Route/
Frequency/
 Timing

Salbutamol 8/14/10 BronchodilatBeta2 Relief and Patient with Fatigue, Monitor respiratory
Iprafropium Nebule or adrenergic prevention cardiac abdominal status, auscultate
q8hours receptor of tachyarrythmi pain, lungs before and
(Combivent) (4-12-8) Beta2 cause bronchospa as, hypertensio after nebulization
Adrenergic bronchodilat sm in hypertropic n,
agonist and ion and patients obstructive dyspepsia, Report treatment
anti vasodilation with airway cardiomyopat tachycardia, failure or
cholinergic obstructive hy and sinusitis, exacerbation of
Anticholiner disease patient with dysuria, respiratory
gic, blocks history of urinary symptoms to
reflexes by Bronchodila hypersensitivi retention, physician
antagonizing tor ty weakness,
action of edema, Do not allow solution
acetylcholin vomiting or mist to enter the
e diarrheal eyes
constipation

DRUG STUDY
Patient’s Name:________________________________________ Age/Gender:_______________
Diagnosis:_____________________________________________

Name of Drug Date Classificatio Mechanism Specific Contraindicati Adverse Nursing

(Brand &Generic) Ordered/ n of Action Indication on Effect/ Side Responsibilities
Dosage/ Effect
Route/
 Frequency/
Timing

Sultamicillin 8/14/10 Anti – Bactericidal Treatment Contraindicat Diarrhea or Assess patient for
70mg 1 tab infective action for ed to constipation infection at the
PO/NGT BID against respiratory hypersensitivi , GI upset beginning and all
(8am – 6pm) streptococci, infections ty throughout therapy
pnuemococc
i, Impaired Observe patient for
enterococci, renal function signs and symptoms
haemophilus of anaphylaxis,
influenzae Pregnancy discontinue drug
and lactation and notify physician
Binds to immediately
bacterial cell
wall causing Report physician if
death symptoms do not
improve
Spectrum
broader
than
penicillin

DRUG STUDY
Patient’s Name:________________________________________ Age/Gender:_______________
Diagnosis:_____________________________________________

Name of Drug Date Classificatio Mechanism Specific Contraindicati Adverse Nursing

(Brand &Generic) Ordered/ n of Action Indication on Effect/ Side Responsibilities
Dosage/ Effect
 Route/
Frequency/
Timing
Multivitamins Multivitamin Vitamins For vitamin Contraindicat Nausea, GI • Take with or
(moriamin forte) 8/14/10 s and and defeciencie ed to patient upset, without foods,
Calcium 1 cap menirals minerals s and as with constipation may be taken
panthothenic PO/NGT contents are supplement malabsorptio , and with meals for
(8am-6pm) absorbed by n syndrome headache better GI
the intestine For anemia and absorption or oil
and into the and hyperphagia discomfort occurs
bloodstream malnutritio
which is n • May discolor
distributed urine yellow
and
consumed
by the body • Do not drink
or stored in milk prior to
the body drinking thids
drug. Take it 1
hour before or 2
hours after to
prevent mal-
absorption.

DRUG STUDY
Patient’s Name:________________________________________ Age/Gender:_______________
Diagnosis:_____________________________________________

Name of Drug Date Classificatio Mechanism Specific Contraindicati Adverse Nursing

(Brand &Generic) Ordered/ n of Action Indication on Effect/ Side Responsibilities
 Dosage/ Effect
Route/
Frequency/
Timing

Fluimucil 8/14/10 Mucolytic N-acetyl Used as Hypersensitivi Nausea. • Administer

sachet 1 sachet agent derivative of mucolytic ty to Rhinorrhea. tetracyclines
+1/2 glass system is for acetylcystein Bronchospa erythromycins,
water used as abnormal; e sm in amphoterecin B ,
OD NGT HS mucolytic viscid asthmatics trypsin and
(8PM) agent to mucus hydrogen
reduce secretions peroxide
viscosity of in separately
mucous tracheotom because they are
secretions. y care incompatible with
acetylcystein
• Instruct that
side effects may
occur foe
productive cough,
nausea and GI
upset
• Have suction
on stand by
• Instruct client
to report to the
nurse on duty for
any severe
abnormalities

DRUG STUDY
Patient’s Name:________________________________________ Age/Gender:_______________
Diagnosis:_____________________________________________
 Name of Drug Date Classificatio Mechanism Specific Contraindicati Adverse Nursing
(Brand &Generic) Ordered/ n of Action Indication on Effect/ Side Responsibilities
Dosage/ Effect
Route/
Frequency/
Timing

Clindamycin 30 mg Lincosamide Inhibits Systemic Allergy to CV: • Do not give IM

ANST antibiotic protein administrati clindamycin, Hypotension injections of more
q6hours synthesis in on; serious history of Cardiac than 600mg;
IVTT susceptible infections asthma or arrest inject deep into
bacteria, caused by other large muscle to
causing cell susceptible allergies. GI: avoid serious
death. strains of Severe problems
anaerobes, colitis,
streptococci nausea • Monitor renal
reserves Vomiting and liver function
use for Diarrhea test and blood
penicillin- Abdominal counts with
allergic pain prolonged therapy
patients/
when • Report severe/
penicillin is watery diarrhea.
in Abdominal pain,
appropriate; inflamed
less toxic mouth/vagina,
anti biotic skinrash/lesion.
( erythromy
cin) should
be
considered

DRUG STUDY
 Patient’s Name:________________________________________ Age/Gender:_______________
Diagnosis:_____________________________________________

Name of Drug Date Classificatio Mechanism of Specific Contraindicati Adverse Nursing

(Brand &Generic) Ordered/ n Action Indication on Effect/ Side Responsibilities
Dosage/ Effect
Route/
Frequency/
Timing

Hydrocortisone 60 g Corticosterio Enters target Replaceme Contraindicat CNS: • Give the drug
q8hours d, short cells and binds nt therapy ed with vertigo, as prescribed
IVTT acting to cytoplasmic in adrenal fungal headache • Take with
receptor: cortical infections, CV: meals or snacks
Adrenal initiates many insufficienc amebiasis, hypotension if GI upset occurs
corticalstero complex y hepatitis B, , shock • Follow doctors
id hormone reactions that vaccinia, or Skin: fragile prescription
are responsible varicella and skin, • Orient client
for its anti- antibiotic- petechea with common
inflammatory resistant EENT: adverse effect
immune infections Cataract,
• Monitor vital
suppressive immuno glaucoma
signs
(glucocoticoid) suppression Endocrine:
and salt Amenorrhea
retaining , irregular
(mineralocotec menstruatio
oid) actions. n
Some actions GI: peptic or
may be esophageal
undesirable, ulcer
depending on Hematologic
drug use. : Sodium
and fluid
retention
 DRUG STUDY
Patient’s Name:________________________________________ Age/Gender:_______________
Diagnosis:_____________________________________________

Name of Drug Date Classificatio Mechanism Specific Contraindicati Adverse Nursing

(Brand &Generic) Ordered/ n of Action Indication on Effect/ Side Responsibilities
Dosage/ Effect
Route/
Frequency/
Timing

Furosemide 10 ml now Loop Inhibits the Acute Contraindicat CNS: • Administer

IVTT diuretic reabsorption pulmonary ed with dizziness, with food or milk
of sodium edema allergic of weakness, to prevent GI
and chloride furosemide, headache, upset
from the or fatigue, • Give early in
proximal sulfonamides blurred vision the day so that
and distal CV: increase urination
renal orthostatic will not disturbed
tubules and hypertention, sleep
the loop of cardiac • Measure and
henle, arrhythmias, records weight to
leading to a thrombophleb monitor fluid
sodium rich itis changes
dieresis. GI: nausea,
vomiting,
anorexia,
constipation
Oral and
gastric
irritation
 DRUG STUDY
Patient’s Name:________________________________________ Age/Gender:_______________
Diagnosis:_____________________________________________

Name of Drug Date Classificatio Mechanism of Specific Contraindicatio Adverse Nursing

(Brand &Generic) Ordered/ n Action Indication n Effect/ Side Responsibilities
Dosage/ Effect
Route/
Frequency/
Timing

Omiprazole Anti- Gastric acid- Short term • Contraind CNS: • Adminster

IVTT secretory pump inhibitor treatment icated with headache, before meals to
agent suppresses of avtive hypersensiti dizziness prevent GI upset
Proton gastric acide duodenal vity to GI: • Administer
pump secretion the ulcer omeprazole diarrhea, antacid with
inhibitor specific or its abdominal omeprazol if
inhibition of the components pain, needed
hydrogen/potass • Use nausea and • Report
ium ATPase cautiously vomiting severe
enzyme system with headache,
at the secretory pregnancy, worsening of
surface of the lactation symptoms,
gastric parietal fever.
cells; blocks the
final step of acid
production.